“High Throughput HLA Typing Approaches Using NGS” – Omixon Talk in Moscow

09/03/2020

Join Omixon for our talk at the Registries of Bone Marrow Donors: Today and Tomorrow conference in Moscow, Russia on March 12! The talk will be presented by Nina Lauterbach, PhD, Senior Field Application Scientist at Omixon. Date: Thursday, March 12, 2020 Venue: Center for the Development of Charity...

Interview with the South African National Blood Service

28/02/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time Dr. Lavendri Govender and Dr. Ute Jentsch from South-African National Blood Service talk about their experiences and thoughts on technology improvements. We...

Announcement – First Omixon Shipment to Kazakhstan

24/02/2020

We are pleased to inform our customers that Omixon have now officially shipped the first Holotype HLA kits for commercial sale to Nur-Sultan, Kazakhstan with the help of our local partner, Dilen s.r.o., our exclusive distributor in the country. “Our national reach and full technical support is now...

Join Omixon for our User Group Meeting at EFI 2020!

03/02/2020

The Omixon Team would like to invite you to our User Group Meeting Luncheon at the EFI Annual Meeting in Glasgow, UK. Join us for an interactive event where you can learn about Omixon’s products, most notably, Holotype HLA, and HLA Twin, as well as the newly released OmniType....

EFS Selects Omixon for HLA Typing by NGS

16/01/2020

Omixon announce that their flagship Holotype HLA assay and software solution as well as Monotype HLA configuration for disease association studies for HLA typing by Next Generation Sequencing (NGS) has been selected as the HLA typing solution of choice by the Etablissement Français du Sang (the French National Blood Service,...